Longitudinal Validation of the Artificial Intelligence Algorithm in Home OCT for Age-Related Macular Degeneration—Report 3
Authors:
Open Access
- 6 August 2025
- journal article
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (2) , 100907
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma US
- U.S. Department of Health and Human Services
- Research to Prevent Blindness (P30-EY026877)
- Notal Vision
- Boehringer Ingelheim
- National Institutes of Health
This publication has 21 references indexed in Scilit:
- Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1Ophthalmology Science, 2025
- Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular DegenerationOphthalmology Retina, 2023
- Prospective, Longitudinal Study: Daily Self-Imaging with Home OCT for Neovascular Age-Related Macular DegenerationOphthalmology Retina, 2022
- Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trialsThe Lancet, 2022
- Prospective, Longitudinal Pilot StudyOphthalmology Science, 2021
- Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2021
- SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United StatesOphthalmology Retina, 2020
- Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep LearningOphthalmology, 2018
- Automated Identification of Lesion Activity in Neovascular Age-Related Macular DegenerationOphthalmology, 2016
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012